The Impact of the SARS-CoV-2 Pandemic (COVID-19) on the Incidence of Newly Diagnosed Multiple Myeloma Patients Using a Federated Network of Real-World Evidence in US and Germany Jan 10, 2024
Real-world patient characteristics and survival outcomes of lenalidomide-refractory vs. lenalidomide-exposed RRMM patients in the HONEUR federated data network Jan 10, 2024
Treatment of multiple myeloma in Germany: an update of a representative multicentre health care survey 2004–2011 Jul 20, 2023
Comparative Effectiveness of Pomalidomide Plus Low-Dose Dexamethasone (POM+LoDEX) in Relapsed and Refractory Multiple Myeloma: Use of Real-World Data in the Absence of Head-to-Head Studies Jul 20, 2023
